National Health Insurance Data Analysis for the Second-Wave Development of Korean Medicine Clinical Practice Guidelines in South Korea
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: After the evidence-based Korean medicine clinical practice guidelines (KMCPGs) for 30 targeted diseases were developed in 2021, 34 diseases have been proposed for the second-wave development of the KM-CPGs. The purpose of this study was to investigate the development priorities of the candidate diseases into the second-wave development of KM-CPGs in south Korea. Methods: In this study, we analyzed the Health Insurance Review and Assessment Service National Patient Sample data from 2017 to 2018 to determine the demand and economic importance of the candidates for the second-wave development of KM-CPGs in real-world clinical settings in Korea. Results: The annual number of visits and patients, annual healthcare expenditure per patient, and healthcare expenditure per institution were analyzed. Musculoskeletal disorders, including sciatica and adhesive capsulitis of the shoulder, were the most important topics regarding the number of visits and patients and annual healthcare expenditure per institution. Specifically, sciatica (52.05% of the total number of visits, 48.34% of the total number of patients, and 42.12% of the total treatment expenditure per institution) showed overwhelmingly high proportions. However, cerebral palsy (36.03% of the total number of inpatient visits and 24.55% of the total number of inpatient patients) was a more important topic in inpatient clinical settings than musculoskeletal conditions or cancer, and healthcare expenditure per patient in this topic had the highest ranking. Furthermore, fractures were found to be highly important in inpatient clinical settings. No patients had influenza A virus infection or posttraumatic stress disorders who visited the KM medical institution of interest. Conclusion: This study highlights the gap between the real-world clinical setting and the research field in some topics. The results of this study can provide guidance for the second-wave development of KM-CPGs in the future.
Abstract
Objectives: After the evidence-based Korean medicine clinical practice guidelines (KMCPGs) for 30 targeted diseases were developed in 2021, 34 diseases have been proposed for the second-wave development of the KM-CPGs. The purpose of this study was to investigate the development priorities of the candidate diseases into the second-wave development of KM-CPGs in south Korea. Methods: In this study, we analyzed the Health Insurance Review and Assessment Service National Patient Sample data from 2017 to 2018 to determine the demand and economic importance of the candidates for the second-wave development of KM-CPGs in real-world clinical settings in Korea. Results: The annual number of visits and patients, annual healthcare expenditure per patient, and healthcare expenditure per institution were analyzed. Musculoskeletal disorders, including sciatica and adhesive capsulitis of the shoulder, were the most important topics regarding the number of visits and patients and annual healthcare expenditure per institution. Specifically, sciatica (52.05% of the total number of visits, 48.34% of the total number of patients, and 42.12% of the total treatment expenditure per institution) showed overwhelmingly high proportions. However, cerebral palsy (36.03% of the total number of inpatient visits and 24.55% of the total number of inpatient patients) was a more important topic in inpatient clinical settings than musculoskeletal conditions or cancer, and healthcare expenditure per patient in this topic had the highest ranking. Furthermore, fractures were found to be highly important in inpatient clinical settings. No patients had influenza A virus infection or posttraumatic stress disorders who visited the KM medical institution of interest. Conclusion: This study highlights the gap between the real-world clinical setting and the research field in some topics. The results of this study can provide guidance for the second-wave development of KM-CPGs in the future.
참고문헌 (13)
- Park HL, "Traditional medicine in China, Korea, and Japan : a brief introduction and comparison", Evid Based Complement Alternat Med, 2012, pp.429103~ (2012)
- 김동수, "A comparative study of the traditional medicine systems of South Korea and Taiwan: Focus on administration, education and license", Integrative Medicine Research, 10(3), pp.1~5 (2021), 한국한의학연구원[DOI]
- Kwon S, "Changes in trust and the use of Korean medicine in South Korea : a comparison of surveys in 2011 and 2014", BMC Complement Altern Med, 17(1), pp.463~ (2017)
- Fischer FH, "High prevalence but limited evidence in complementary and alternative medicine : guidelines for future research", BMC Complement Altern Med, 14, pp.46~ (2014)
- Park J, "The provision and utilization of traditional Korean medicine in South Korea : implications on integration of traditional medicine in a developed country", Healthcare(Basel), 9(10), pp.1379~ (2021)
- Kim L, "A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples", Epidemiol Health, 36, pp.e2014008~ (2014)
- Eardley S, "A systematic literature review of complementary and alternative medicine prevalence in EU", Forsch Komplementmed, 19(Suppl 2), pp.18~28 (2012)
- Oskoui M, "Complementary and alternative therapy use in children with cerebral palsy", Can J Neurol Sci, 48(3), pp.408~414 (2021)
- Sprague S, "Complementary and alternative medicine use in patients with fractures", Clin Orthop Relat Res, 463, pp.173~178 (2007)
- Ng Jeremy Y, "What traditional, complementary, and integrative medicine recommendations exist across osteoporosis clinical practice guidelines? A systematic review and quality assessment", Integrative Medicine Research, 11(2), pp.1~8 (2022), 한국한의학연구원[DOI]
- Luo X, "Clinical evidence on the use of Chinese herbal medicine for acute infectious diseases : an overview of systematic reviews", Front Pharmacol, 13, pp.752978~ (2022)
- Ang L, "Herbal medicine for the treatment of Coronavirus disease 2019(COVID-19) : a systematic review and meta-analysis of randomized controlled trials", J Clin Med, 9(5), pp.1583~ (2020)
- Wahbeh H, "Complementary and alternative medicine for posttraumatic stress disorder symptoms : a systematic review", J Evid Based Complementary Altern Med, 19(3), pp.161~175 (2014)